Статус неизвестен
Фаза IV
Беларусь
ВЕМУРАФЕНИБ · F.Hoffmann-La Roche Ltd, Basel
An Open-Label, Extension (Rollover) Study of Vemurafenib in Patients With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol